Abstract:Gliomas are heterogeneous brain tumors with prognostically-significant subtypes and few risk factors. IDH-wildtype glioblastoma, the most common subtype, carries a dismal prognosis. Using the largest GWAS dataset with histological (11,304 cases, 304,523 controls) and molecular (3,418 cases, 8,156 controls) subtypes, we analyzed the plasma and brain proteome to uncover proteins associated with glioma susceptibility. Using protein quantitative trait loci (pQTL) for 1,776 proteins in brain tissue, we identified 21 candidate proteins, including 9 associations with high probability (>70%) of colocalization (shared causal genetic variants for glioma risk and protein abundance). We confirmed known risk genes such as EGFR (p=1.9×10 -35 ) and D2HGDH (p=1.1×10 -5 ). We also identified novel risk proteins, including ENPP6, a choline phosphodiesterase overexpressed in glioma, for IDH-wildtype glioblastoma (OR=0.62, p=7.6×10 -5 ), and galectin-3, a lectin encoded by a tumor fitness gene in CRISPR screens of glioma proliferation and a clinical drug target, for glioma overall (OR=1.37, p=1.3×10 -5 ). Analyses of the plasma proteome using pQTLs for 1,362 proteins from 3 cohorts (N=88,838) identified 9 colocalized associations in whole blood. Most risk signals were subtype-specific, such as CRELD1 (p=2.5×10 -5 ) for triple-negative glioblastoma. We found three candidate risk proteins for IDH-mutant 1p19q-intact glioma: immunoglobulin glycoprotein BCAM (p=9.6×10 -8 ), neurotrophin receptor SorCS2 (p=3.6×10 -5 ) and immune checkpoint PD-1 (p=1.1×10 -5 ). Interestingly, genetically-predicted PD-1 levels had a larger effect on IDH-mutant 1p19q-intact (OR=2.75, 95% CI=1.61-4.69) than IDH-wildtype (OR=0.73, 95% CI=0.51-1.05) tumors, suggesting germline differences in immune checkpoint mechanisms among subtypes. For all colocalized candidates, genetically-predicted protein abundance was correlated with cis-regulated transcriptional activity in brain tissue. For example, genetically-predicted SORCS2 gene expression in brain tissue was associated with plasma SorCS2 levels (Z=16.1, p=1.1×10 -68 ). Our analysis identified candidate proteins involved in immune response and neuronal proliferation, which may enable prioritization of drug targets and provide insight into disease mechanisms for glioma.

Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci

Epco-58. Integrative Proteogenomic Analyses Reveal Insights Into Subtype-Specific Glioma Risk

Epid-19. Interaction Between Germline And Somatic Genetics To Elucidate Risk Of Adult Diffuse Glioma

Epco-53. Characterizing The Functional Impact Of Germline-Inherited Risk Alleles In Glioma Evolution

Genome-wide association study of glioma and meta-analysis

Polymorphisms of TREH, IL4R and CCDC26 Genes Associated with Risk of Glioma.

Selected Polymorphisms of GSTP1 and TERT Were Associated with Glioma Risk in Han Chinese.

Fine-Mapping Of A Region Of Chromosome 5p15.33 (Tert-Clptm1l) Suggests A Novel Locus In Tert And A Clptm1l Haplotype Are Associated With Glioma Susceptibility In A Chinese Population

RTEL1 Tagging SNPs and Haplotypes Were Associated with Glioma Development

Fine Mapping Analysis of a Region of 20q13.33 Identified Five Independent Susceptibility Loci for Glioma in a Chinese Han Population.

Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.

Classification Based on Mutations of TERT Promoter and IDH Characterizes Subtypes in Grade II/III Gliomas.

The Immunohistochemical Expression of IDH1, ATRX, PHH3, P53, Ki67 and Molecular Status of IDH, 1p19q, MGMTp, TERTp in Gliomas: an Analysis of 568 Patients in a Single Center

Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis

High-grade Gliomas with Isocitrate Dehydrogenase Wild-Type and 1p/19q Codeleted: Atypical Molecular Phenotype and Current Challenges in Molecular Diagnosis.

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma

[Prognostic Significance of Combined TERT and IDH Gene Mutation Analysis in Diffusely Infiltrating Gliomas].

Prognostic relevance of genetic alterations in diffuse lower-grade gliomas

Genotype-based Gene Signature of Glioma Risk.

IDH Clonal Heterogeneity Segregates a Subgroup of Non‐1p/19q Codeleted Gliomas with Unfavourable Clinical Outcome

Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification